Search

1. Searching for savings in Medicare drug price negotiations

Author(s):

Cubanski, Juliette, author
Neuman, Tricia, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, April 2018

Subject(s):

Drug Costs
Medicare Part D -- economics
Negotiating
Prescription Drugs -- economics
United States

2. How does the Trump Administration drug pricing blueprint affect Medicaid?

Author(s):

Young, Katherine, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, May 2018

Subject(s):

Cost Control
Drug Costs
Medicaid -- economics
Prescription Drugs -- economics
United States
United States.

3. A sense of déjà vu: the debate surrounding state biosimilar substitution laws

Author(s):

Purvis, Leigh, author

Publication:

Washington, D.C. : AARP Public Policy Institute, September 2014

Subject(s):

Biological Products -- economics
Biological Products -- therapeutic use
Biosimilar Pharmaceuticals -- economics
Biosimilar Pharmaceuticals -- therapeutic use
Drug Costs
Drug Substitution
Legislation, Drug
United States
United States. Food and Drug Administration
United States.

4. The Pharmaceutical Industry Must Join America

Publication:

Produced: 22 January 1960

Subject(s):

Drug Industry
Drug Costs
Antipsychotic Agents
Phenothiazines
Hospitals, Psychiatric
Health Policy

Archival Collection:

The Mike Gorman Papers (Profiles in Science)

5. Calculation of potential inflation-indexed rebates for Medicare Part B drugs

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017

Subject(s):

Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
United States
United States. Department of Health and Human Services

6. Medicare Part B drug payments: impact of price substitutions based on 2014 average sales prices

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017

Subject(s):

Drug Costs
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Medicare Part B -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

7. Medicare Part B drug payments: impact of price substitutions based on 2015 average sales prices

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017

Subject(s):

Drug Costs
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Medicare -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

8. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2017

Subject(s):

Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
Prospective Payment System
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)
Healthcare common procedure coding system

9. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2017

Subject(s):

Drug Costs
Drug Industry -- economics
Medicaid -- economics
Pharmaceutical Preparations -- classification
Pharmaceutical Preparations -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

10. Medicare Part B drug payments: impact of price substitutions based on 2016 average sales prices

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2018

Subject(s):

Drug Costs
Insurance, Health, Reimbursement
Medicare Part B -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)